Lower-dose GLP-1
MICRODOSING
A lower-dose GLP-1 program, prescribed and dispensed by an independent licensed telehealth network. Your provider sets the dose and schedule.


Semaglutide
This compounded GLP-1 therapy is used for weight management under the guidance of a licensed provider.
Injection · Weekly
Each plan is a continuous subscription. Standard plans renew automatically every 4 weeks until you cancel, and you may cancel at any time. Every shipment includes everything you need to take your medication.
Compounded medications are not FDA-approved.
Side effects and safetyPrices are per 4 weeks. The telehealth provider bills you directly. Each evaluation and checkout covers one medication. Longer plans are available at checkout. An independent licensed medical professional reviews every evaluation and decides whether a prescription is appropriate.
The semaglutide, tirzepatide, sermorelin, and NAD+ referenced on this site are compounded preparations, which are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Other peptides discussed on this site for educational purposes, including BPC-157 and TB-500, are investigational, are not FDA-approved, and are not available through the telehealth network. Prescription therapies referenced on this site are evaluated, prescribed, and billed by independent, state-licensed providers within a credentialed telehealth network and dispensed by licensed compounding pharmacies. Each medication is prepared by a licensed pharmacy and carries that pharmacy's label. Truthe Health does not prescribe, dispense, or bill for any prescription product. Statements on this site have not been evaluated by the FDA. Truthe dietary supplements are not intended to diagnose, treat, cure, or prevent any disease.
Have you already ordered a prescription, such as NAD+, Sermorelin, Metabolism Boost (B12), or a GLP-1 medication? Log in to Truthe Rx.
What's in it
Semaglutide Microdose Injection
GLP-1 receptor agonist
- ·Compounded formulation, not an FDA-approved product
- ·GLP-1 receptor agonist
- ·Provider-selected
- ·Weekly subcutaneous injection
Tirzepatide Microdose Injection
Dual GIP and GLP-1 receptor agonist
- ·Compounded formulation, not an FDA-approved product
- ·GIP and GLP-1 receptor agonist
- ·Provider-selected
- ·Weekly subcutaneous injection
Complete your intake. Five minutes, HIPAA-secure. Your medical history, current medications, and what you are trying to achieve.
Independent provider review. A licensed telehealth provider reviews your intake, exercises clinical judgment, and prescribes if appropriate. Never your surgeon.
If prescribed, compounded and shipped. Your medication is compounded by an independent licensed compounding pharmacy and shipped directly, with check-ins as your provider directs.
- Adults whose provider determines that GLP-1 therapy is clinically appropriate
- Individuals who have tried diet and exercise alone without sustained results
- People who want a provider-supervised alternative to over-the-counter weight loss products
No. These are compounded formulations. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed, and it has stated that some compounded semaglutide products use salt forms that are different active ingredients from those in the approved drugs.
Published trials of GLP-1 medications studied branded products, and no trial result describes the compounded formulations available through this program.
Appetite signaling
GLP-1 receptor agonists act on appetite signalling and slow gastric emptying. Individual responses vary, and your provider monitors yours.
Ongoing clinical oversight
Your provider monitors your response at regular check-ins and adjusts the plan.
- Licensed provider consultation and prescription
- Compounded medication shipped to your door
- Personalized dosing protocol
- Regular provider check-ins and monitoring
- Secure messaging with your care team
What does microdosing mean here?
It is a separate program that uses the same GLP-1 medications, not a different medication. Your provider sets the dose and schedule.
How does a provider decide whether this program is appropriate?
The provider reviews your history, your current medications, your tolerance of previous therapy if you have had any, and what you are trying to achieve. Dosing is a clinical judgment made for you, not a product you select.
Is this FDA-approved?
No. These are compounded formulations. The FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed, and it has stated that some compounded semaglutide products use salt forms that are different active ingredients from those in the approved drugs. Published trial results for the branded products do not describe the compounded formulations available through this program.
What are the side effects?
The FDA labels for the branded GLP-1 medications list nausea, diarrhea, vomiting, constipation and abdominal pain among the most common adverse reactions. Your provider screens at intake for contraindications, including a personal or family history of medullary thyroid carcinoma or MEN2 and prior serious hypersensitivity to the medication, and for warnings, including a history of pancreatitis.
How is this different from the weight loss program?
It uses the same class of medication on a separate program. Which one fits you is a clinical decision, and your provider will tell you if a different program is more appropriate. Your provider sets the dose and schedule.
This program is available now through an independent licensed telehealth network. A licensed provider in that network reviews your intake and decides whether a prescription is appropriate for you.